FDA Issues Notice on Generic Drug User Fees
July 13, 2025
July 13, 2025
WASHINGTON, July 13 (TNSFR) -- The U.S. Department of Health and Human Services Food and Drug Administration has issued a notice entitled "Generic Drug User Fees; Consultation Meetings on Reauthorization of Generic Drug User Fee Amendments for Fiscal Years 2028-2032; Request for Notification of Intention to Participate."
This notice seeks participation from interested parties, including patient and consumer advocacy groups, health care professionals and scientific and acad . . .
This notice seeks participation from interested parties, including patient and consumer advocacy groups, health care professionals and scientific and acad . . .